Shenzhen WOTE Advanced Materials Co., Ltd (002886.SZ)
Shenzhen, CN
Shenzhen WOTE Advanced Materials Co., Ltd., established in 2001 and headquartered in Shenzhen, China, operates globally as a comprehensive provider in the field of polymer materials and engineering plastics. The company specializes in the entire product lifecycle, encompassing research, development, production, sales, trade, and servicing for both domestic and international clients. Their extensive product portfolio includes a diverse range of high-performance and high-temperature polymers like PES, PEEK, LCP, and polyfang ether ketones. They also offer specialized materials such as polysaccharides, custom nylon formulations, and various PTFE (polytetrafluoroethylene) products, including sheets, rods, pipes, films, gaskets, roots, and elastic bands. Furthermore, WOTE provides common engineering plastics like PBT and ABS, alongside advanced solutions for carbon fiber enhancement, electromagnetic shielding, and a selection of standard and functional elastomers and plastic series.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -3.01% | +6.83% | +31.09% | +13.52% | +45.85% | +31.81% | +40.97% | +60.57% | +101.90% | +282.75% | +282.75% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 1 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Chemicals - Specialty: +4.7%+8.2% ★ Q1'26: +16.7% (vs Q1'25)
-
EPS growth Chemicals - Specialty: +13.2%+71.4% ★ Q1'26: +116.1% (vs Q1'25)
-
FCF margin FCF growth · Chemicals - Specialty: +44.1%+3.1% Q1'26: +4.2% (vs Q1'25)
-
EBIT margin Chemicals - Specialty: +8.8%+4.8% Q1'26: +2.7% (vs Q1'25)
-
ROIC Chemicals - Specialty: +5.6%+3.9% Q1'26: +1.7% (vs Q1'25)
-
Share dilution Chemicals - Specialty: +0.1%+1.8% Q1'26: -1.5% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Chemicals - Specialty: 0.18×5.94× Q1'26: 29.57× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 1 Rev. Ana. 1 EPS Ana. |
Dec 2027 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
808.17M
est: 808.10M (+0.0%)
|
900.16M
est: 1.02B (-11.7%)
|
1.15B
est: 1.01B (+13.7%)
|
1.54B
est: 1.68B (-8.5%)
|
2.69B
est.
|
1.54B
est: 3.77B (-59.2%)
|
1.49B
est: 3.77B (-60.5%)
|
1.90B
est: 1.84B (+3.0%)
|
2.05B
est: 2.12B (-3.2%)
|
2.59B
2.59B – 2.59B
+22.1% YoY
|
3.00B
3.00B – 3.00B
+16.1% YoY
|
| EBITDA |
73.84M
est: 69.47M (+6.3%)
|
101.16M
est: 87.61M (+15.5%)
|
122.34M
est: 87.16M (+40.4%)
|
126.30M
est: 144.70M (-12.7%)
|
231.53M
est.
|
127.62M
est: 324.14M (-60.6%)
|
96.36M
est: 324.14M (-70.3%)
|
166.34M
est: 155.54M (+6.9%)
|
214.93M
est: 178.90M (+20.1%)
|
218.45M
218.45M – 218.45M
+22.1% YoY
|
253.57M
253.57M – 253.57M
+16.1% YoY
|
| EBIT |
52.74M
est: 36.99M (+42.6%)
|
75.14M
est: 46.65M (+61.1%)
|
91.23M
est: 46.41M (+96.6%)
|
89.50M
est: 77.05M (+16.2%)
|
123.28M
est.
|
52.18M
est: 172.59M (-69.8%)
|
45.42M
est: 172.59M (-73.7%)
|
77.31M
est: 77.95M (-0.8%)
|
99.00M
est: 89.65M (+10.4%)
|
109.47M
109.47M – 109.47M
+22.1% YoY
|
127.08M
127.08M – 127.08M
+16.1% YoY
|
| Net Income |
35.05M
est: 46.06M (-23.9%)
|
47.33M
est: 78.30M (-39.5%)
|
64.74M
est: 69.09M (-6.3%)
|
63.22M
est: 78.30M (-19.3%)
|
161.81M
est.
|
5.90M
est: 253.16M (-97.7%)
|
14.61M
est: 253.16M (-94.2%)
|
36.60M
est: 45.25M (-19.1%)
|
64.40M
est: 45.25M (+42.3%)
|
101.14M
101.14M – 101.14M
+123.5% YoY
|
151.71M
151.71M – 151.71M
+50.0% YoY
|
| SGA |
51.73M
est: 21.74M (+138.0%)
|
75.06M
est: 27.41M (+173.8%)
|
71.18M
est: 27.27M (+161.0%)
|
91.09M
est: 45.28M (+101.2%)
|
72.44M
est.
|
129.76M
est: 101.42M (+27.9%)
|
114.50M
est: 101.42M (+12.9%)
|
141.89M
est: 117.50M (+20.8%)
|
48.63M
est: 135.15M (-64.0%)
|
165.03M
165.03M – 165.03M
+22.1% YoY
|
191.57M
191.57M – 191.57M
+16.1% YoY
|
| EPS |
0.18
est: 0.18 (+2.0%)
|
0.26
est: 0.30 (-13.3%)
|
0.31
est: 0.26 (+17.1%)
|
0.28
est: 0.30 (-6.7%)
|
0.62
est.
|
0.02
est: 0.97 (-97.6%)
|
0.06
est: 0.97 (-93.4%)
|
0.14
est: 0.17 (-17.6%)
|
0.24
est: 0.17 (+41.2%)
|
0.38
0.38 – 0.38
+123.5% YoY
|
0.57
0.57 – 0.57
+50.0% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | C+ | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-28 | C+ | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-27 | C+ | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-26 | C+ | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-25 | C+ | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-22 | C+ | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-21 | C+ | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-20 | C+ | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-19 | C+ | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-18 | C+ | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-15 | C+ | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-14 | C+ | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-13 | C+ | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-12 | C+ | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-11 | C+ | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-08 | C+ | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-07 | C+ | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-06 | C+ | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-30 | C+ | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-29 | C+ | 2/5 | 1/5 | 3/5 | 5/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-28 | C+ | 2/5 | 1/5 | 3/5 | 5/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-27 | C+ | 2/5 | 1/5 | 3/5 | 5/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-24 | C+ | 2/5 | 1/5 | 3/5 | 5/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-23 | C+ | 2/5 | 1/5 | 3/5 | 5/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-22 | C+ | 2/5 | 1/5 | 3/5 | 5/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-21 | C+ | 2/5 | 1/5 | 3/5 | 5/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-20 | C+ | 2/5 | 1/5 | 3/5 | 5/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-17 | C+ | 2/5 | 1/5 | 3/5 | 5/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-16 | C+ | 2/5 | 1/5 | 3/5 | 5/5 | 1/5 | 1/5 | 2/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Jin Xu | Deputy General Manager | — | male |
| Liang Zhang | Deputy GM & Secretary of the Board | — | male |
| Yu Chen | Financial Director & Accounting Supervisor | — | male |
| Zheng He | GM & Director | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 002886.SZ
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
